World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
25883
World Ranking
14634
National Ranking
7404

Chul Ahn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Chul Ahn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 544 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Chul Ahn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Chul Ahn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2015 - Fellow of the American Statistical Association (ASA)

Overview

Chul Ahn is affiliated with The University of Texas Southwestern Medical Center in the United States. Their primary field of study is Medicine, with a particular focus on Oncology and related subfields such as Pulmonary and Respiratory Medicine, Cancer Research, Statistics and Probability, and Radiology, Nuclear Medicine and Imaging.

Their research covers several main topics, including Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Advanced Radiotherapy Techniques, Breast Cancer Treatment Studies, Statistical Methods and Bayesian Inference, Lung Cancer Diagnosis and Treatment, and Nutrition and Health in Aging.

Chul Ahn has contributed to a significant number of scientific publications. Frequent publication venues include:

  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • American Journal of Clinical Oncology
  • Cancer Research
  • Blood

Their frequent co-authors comprise:

  • Robert Timmerman
  • Nina N. Sanford
  • Puneeth Iyengar
  • Raquibul Hannan
  • David J. Sher

Selected recent papers authored by or including Chul Ahn are:

  • Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status, 2021, JAMA Oncology
  • Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC), 2020, Journal of Clinical Oncology
  • Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer, 2022, European Urology Oncology
  • Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000-2017, 2020, Journal of the National Comprehensive Cancer Network

Chul Ahn was awarded the distinction of Fellow of the American Statistical Association (ASA) in 2015.

Best Publications

  • Mutations in smooth muscle α-actin ( ACTA2 ) lead to thoracic aortic aneurysms and dissections

    Dong Chuan Guo;Hariyadarshi Pannu;Van Tran-Fadulu;Christina L. Papke

  • Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

    Puneeth Iyengar;Zabi Wardak;David E. Gerber;Vasu Tumati

  • Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥62 years of age

    Wilbert S. Aronow;Wilbert S. Aronow;Chul Ahn;Chul Ahn

  • Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

    Wilbert S Aronow;Chul Ahn;Itzhak Kronzon;Martin E Goldman

  • Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes—DRD2, DβH, and DAT1

    David E. Comings;S. Wu;Connie Chiu;Robert H. Ring

  • Effect of Propranolol Versus No Propranolol on Total Mortality Plus Nonfatal Myocardial Infarction in Older Patients With Prior Myocardial Infarction, Congestive Heart Failure, and Left Ventricular Ejection Fraction ¢40% Treated With Diuretics Plus Angiotensin- Converting Enzyme Inhibitors

    Wilbert S Aronow;Chul Ahn;Itzhak Kronzon;Itzhak Kronzon;Itzhak Kronzon

  • Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants***

    John D. Reveille;Michael Fischbach;Terry McNearney;Alan W. Friedman

  • Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

    Samir Gupta;Samir Gupta;Ethan A. Halm;Don C. Rockey;Marcia Hammons

  • A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma

    Alina M Suris;Jessica Link-Malcolm;Kathleen Chard;Kathleen Chard;Chul Ahn

  • Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population-Based Study

    Dhaval Kolte;Sahil Khera;Wilbert S. Aronow;Chandrasekar Palaniswamy

  • Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset

    John D. Reveille;Joann M. Moulds;Chul Ahn;Alan W. Friedman

  • Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer

    Puneeth Iyengar;Brian D. Kavanagh;Zabi Wardak;Irma Smith

  • Accuracy of clinical judgment in neonatal jaundice.

    Virginia A. Moyer;Chul Ahn;Stephanie Sneed

  • Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors

    Terry A. McNearney;Terry A. McNearney;John D. Reveille;Michael Fischbach;Alan W. Friedman

  • Choline Deficiency Causes Reversible Hepatic Abnormalities in Patients Receiving Parenteral Nutrition: Proof of a Human Choline Requirement: A Placebo-Controlled Trial

    Alan L. Buchman;Marvin E. Ament;Mir Sohel;Mark Dubin

  • Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States

    Sahil Khera;Dhaval Kolte;Tanush Gupta;Kathir Selvan Subramanian

  • Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment

    Wilbert S Aronow;Devraj Nayak;Steven Woodworth;Chul Ahn

  • Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.

    Arthur E Frankel;Jung H Woo;Chul Ahn;Naveen Pemmaraju

  • The impact of cancer pain education on family caregivers of elderly patients.

    B. R. Ferrell;M. Grant;J. Chan;C. Ahn

  • Voluntary childlessness is increased in women with inflammatory bowel disease.

    Sheetal R. Marri;Chul Ahn;Alan L. Buchman

Frequent Co-Authors

Wilbert S. Aronow
Wilbert S. Aronow New York Medical College
Itzhak Kronzon
Itzhak Kronzon Lenox Hill Hospital
Robert Timmerman
Robert Timmerman The University of Texas Southwestern Medical Center
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Celette Sugg Skinner
Celette Sugg Skinner The University of Texas Southwestern Medical Center
Ethan A. Halm
Ethan A. Halm The University of Texas Southwestern Medical Center
Frank C. Arnett
Frank C. Arnett The University of Texas Health Science Center at Houston
George Somlo
George Somlo City Of Hope National Medical Center
Amit G. Singal
Amit G. Singal The University of Texas Southwestern Medical Center
James H. Doroshow
James H. Doroshow National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens the door to numerous related online degrees and flexible career pathways. For nurses seeking to advance their qualifications, bridge programs offer a direct route. Consider programs like adn to np, which enable registered nurses with an associate degree to progress to a nurse practitioner role with a master’s degree, often through an online format.

Those passionate about food science and preventive health can pursue an online nutritionist degree, preparing for expanding career opportunities in nutrition education and wellness coaching.

For anyone interested in healthcare leadership or administration, accredited online mha programs (Master of Health Administration) offer advanced management training ideal for hospital and healthcare sector roles.

Registered nurses seeking to complete their bachelor’s degree more flexibly can look into rn to bsn without clinicals programs, which streamline the path to a BSN without requiring additional hands-on clinical hours.

These educational pathways provide numerous options for students looking to build or advance a career in healthcare, all with the flexibility of online study.

Best Scientists Citing Chul Ahn

Trending Scientists